Cite

Fig. 1.

Example of vaccine-associated adenopathy in a 66-year-old female patient undergoing breast ultrasound for routine breast imaging with history of breast cancer in the left breast. A. US in the left shoulder showing left axillary adenopathy (22 mm) with fatty hilum and thickened cortex. B. A core biopsy was performed. C. The histology was negative for lymph node malignancy (normal lymphocytes and histiocytes in hematoxylin-eosin staining)
Example of vaccine-associated adenopathy in a 66-year-old female patient undergoing breast ultrasound for routine breast imaging with history of breast cancer in the left breast. A. US in the left shoulder showing left axillary adenopathy (22 mm) with fatty hilum and thickened cortex. B. A core biopsy was performed. C. The histology was negative for lymph node malignancy (normal lymphocytes and histiocytes in hematoxylin-eosin staining)

Fig. 2.

Example of vaccine-associated adenopathy in a 29-year-old female undergoing breast ultrasound for routine breast imaging due to increased breast density. A. US in the left shoulder showing asymmetric left axillary adenopathy (18 mm) with preserved fatty hilum but irregular cortex. B. Four-week follow-up: axillary sonography of the same patient demonstrates decreased size (13 cm) and some residual cortical thickening. C. Eight-week follow-up: axillary ultrasound shows normal sized lymph node
Example of vaccine-associated adenopathy in a 29-year-old female undergoing breast ultrasound for routine breast imaging due to increased breast density. A. US in the left shoulder showing asymmetric left axillary adenopathy (18 mm) with preserved fatty hilum but irregular cortex. B. Four-week follow-up: axillary sonography of the same patient demonstrates decreased size (13 cm) and some residual cortical thickening. C. Eight-week follow-up: axillary ultrasound shows normal sized lymph node

Breast ultrasound features of axillary lymph nodes

Number of patient Patient age (years) Previous breast cancer US feature axillary lymph node: axillary lymph node side US feature axillary lymph node: size (mm of short-axis) US feature axillary lymph node: focal cortical thickening US feature axillary lymph node: visible hilar fat US BI-RADS Performed biopsy Histology after biopsy Vaccination date US date
1 29 No Left 18 No Yes E3 No No 02/2021 03/2021
2 66 Yes: in 2017 IDC in left breast with negative ipsilateral axillary lymph nodes Left 22 No Yes E4b Yes normal lymphocytes and histiocytes in hematoxylin-eosin staining 02/2021 03/2021
3 34 No Right 11 Yes Yes E3 No 02/2021 03/2021
4 54 Yes: in 2015 DCIS in left breast with negative ipsilateral axillary lymph nodes Left 23 No Yes E4b Yes normal lymphocytes and histiocytes in hematoxylin-eosin staining 03/2021 04/2021
5 74 No Left 15 Yes Yes E3 No 03/2021 04/2021
6 46 Yes: in 2018 IDC in left breast with negative ipsilateral axillary lymph nodes Left 13 Yes Yes E4b Yes normal lymphocytes and histiocytes in hematoxylin-eosin staining 03/2021 05/2021
7 76 Yes: in 2018 IDC in right breast with negative ipsilateral axillary lymph nodes Right 20 No Yes E4b Yes normal lymphocytes and histiocytes in hematoxylin-eosin staining 04/2021 05/2021
8 59 Yes: in 2020 IDC in left breast with negative ipsilateral axillary lymph nodes Left 20 No Yes E4b Yes normal lymphocytes and histiocytes in hematoxylin-eosin staining 04/2021 05/2021
9 39 No Left 22 No Yes E3 No 05/2021 05/20121
10 28 No Right 20 Yes Yes E3 No 05/2021 05/2021
eISSN:
2451-070X
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Basic Medical Science, other